Drug distributors like, McKesson, Cardinal Health and Amerisource-Bergen have proposed paying $10 billion to settle all claims related their respective roles in the opioid epidemic in the U.S. This according to a report from Bloomberg. We spoke to William Stilley the CEO at Adial Pharmaceuticals about the offers and the opioid epidemic.